IQVIA Holdings vs BeOne Medicines
IQVIA Holdings (IQV), health care, and BeOne Medicines (ONC), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
BeOne Medicines is worth $47.2B on the stock market and IQVIA Holdings $42.5B: BeOne Medicines is valued at 11% more. IQVIA Holdings trades at 31.3 times earnings and BeOne Medicines at 53.0; operating margins in their latest fiscal years were 13.4% and 8.37%. Over the past year IQVIA Holdings's share price has moved +21.8% and BeOne Medicines's +13.0%.
Key facts
- IQVIA Holdings market value
- $42.5B
- BeOne Medicines market value
- $47.2B
- IQVIA Holdings P/E
- 31.3
- BeOne Medicines P/E
- 53.0
- IQVIA Holdings revenue
- $16.3BFY to 2025-12-31
- BeOne Medicines revenue
- $5.3BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | IQVIA Holdings | BeOne Medicines |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $42.5Blower | $47.2Bhigher |
| Revenue | $16.3Bhigher | $5.3Blower |
| Earnings | $1.4Bhigher | $286.9Mlower |
| Employees | 95,000higher | 12,000lower |
| Total assets | $29.9Bhigher | $8.2Blower |
| Valuation | ||
| P/E | 31.3lower | 53.0higher |
| P/S | 2.6lower | 8.8higher |
| P/B | 6.4 | — |
| Dividend yield | 0.00% | — |
| Profitability | ||
| Operating margin | 13.4%higher | 8.37%lower |
| Balance sheet | ||
| Net assets | $6.5Bhigher | $4.4Blower |
| Total liabilities | $23.3Bhigher | $3.8Blower |
| Total debt | $15.7Bhigher | $1Blower |
| Cash on hand | $2Blower | $4.5Bhigher |
| Price change | ||
| Today | -2.69%lower | +0.48%higher |
| 1 year | +21.8%higher | +13.0%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
IQVIA Holdings only (8)
- Eric Bannasch12.1%
- Andrew Wellington4.5%
- Anthony Bozza3.2%
- Bill Nygren3.1%
- Harry Burn2.8%
- Edgar Wachenheim1.8%
- Tom Gayner0.1%
- Charles Brandes (founder)0.1%
BeOne Medicines only (6)
Percentages are each holding's share of that investor's reported portfolio. Who owns IQV · Who owns ONC
More on IQVIA Holdings
Further comparisons
IQVIA Holdings against its closest peers
BeOne Medicines against its closest peers
Learn
Questions and answers
Which is bigger, IQVIA Holdings or BeOne Medicines?
By market value, BeOne Medicines is the larger: $47.2B against $42.5B for IQVIA Holdings. By revenue in its latest fiscal year, IQVIA Holdings is the larger: $16.3B against $5.3B for BeOne Medicines.
Which has the higher P/E ratio?
BeOne Medicines: 53.0, against 31.3 for IQVIA Holdings. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
IQVIA Holdings: 13.4%, against 8.37% for BeOne Medicines. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
IQVIA Holdings: $15.7B, against $1B for BeOne Medicines. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both IQVIA Holdings and BeOne Medicines?
None of the tracked superinvestors holds both in their latest 13F filing. 8 hold IQVIA Holdings and 6 hold BeOne Medicines.
Cite this page
Funkfolio, “IQVIA Holdings vs BeOne Medicines”, data as of 18 November 2026. https://funkfolio.com/compare/iqv-vs-onc
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.